One of the primary issues seen in the life sciences industry concerns multiple complex medications. Every medication developed has different characteristics based on the disease state, the size of the patient population, and the product’s route of administration. “And, in order to design the right patient support program for the medication, it is necessary to understand the optimal path of patients undergoing a particular therapy,” says Sahney. For this, PharmaCord has developed a unique approach called 3-D, where PharmaCord’s team engages with clients in three phases—discovery, development, and deployment. “This approach helps us understand the many different characteristics of the product in designing a PSP that helps provide patients with excellent experiences,” adds Sahney.
Another common issue experienced is apropos of the accessibility of insightful data. While pharmaceutical manufacturers continue to confront the changing dynamics of a product’s lifecycle, it is necessary they have access to reliable, comprehensive, and timely data that prepares them for what lies ahead. “We have created a device-agnostic reporting platform called CORsights for the same,” reveals Sahney. CORsights provides pharma/biopharma companies with the right information in real time to help them navigate the market factors that can affect their products.
CORsights provides pharma and biopharma companies with the right information in real time to help them navigate the market factors that can affect their products
An aspect that truly differentiates PharmaCord is the agility and ability of its solutions to adapt to clients’ needs. This agility was put to the test when a client asked PharmaCord to develop a tool that provides patients with a real-time benefit check on demand. “The client wanted a solution for patients, which enables them to go to the product’s website, input a few pieces of information, and learn their cost for a particular drug,” explains Sahney. “Using myCORconnect—our suite of consumer-facing patient support and access tools—the client was able to get the required information.” This also made myCORconnect a viable solution that improves patient connectivity and helps enhance their experience in therapy.
Established in 2017, PharmaCord has already carved a niche within the pharma and life sciences industry through its proprietary platform that acts as the nexus for its services. Forging ahead, the company hopes to keep growing at a steady pace and continue investing in people, facilities, and technology to adapt to the evolving healthcare landscape. “It is a very exciting time to be an innovator in this space, and we are keen to explore the various market opportunities,” concludes Sahney.